Complementary pharmacological and toxicological characterization data on the pharmacological profile of N-(2,6-dichlorophenyl)-2-(4-methyl-1-piperidinyl) acetamide

Myrna Déciga-Campos, Gabriel Navarrete-Vázquez, Francisco Javier López-Muñoz, Tadeusz Librowski, Amanda Sánchez-Recillas, Victor Yañez-Pérez, Rolffy Ortiz-Andrade

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

This text presents complementary data corresponding to pharmacological and toxicological characterization of N-(2,6-dichlorophenyl)-2-(4-methyl-1-piperidinyl)acetamide (LIA) compound. These data support our research article entitled “Pharmacological profile of N-(2,6-dichlorophenyl)-2-(4-methyl-1-piperidinyl)acetamide, a novel analog of lidocaine” Déciga-Campos M., Navarrete-Vázquez G., López-Muñoz F.J., Librowski T., Sánchez-Recillas A., Yañez-Pérez V., Ortiz-Andrade R. (2016) [1]. Toxicity was predicted through the ACD/ToxSuite software and evaluated in vivo using brine shrimp larvae (Artemia salina L.) and mice. Also, we used the micronucleus assay to determine genotoxicity. We used the platform admetSAR to predict absorption properties of LIA and lidocaine.

Original languageEnglish
Pages (from-to)1007-1012
Number of pages6
JournalData in Brief
Volume8
DOIs
StatePublished - Sep 2016

Keywords

  • Lidocaine
  • N-(2,6-dichlorophenyl)-2-(4-methyl-1-piperidinyl)acetamide
  • Toxicity

Fingerprint

Dive into the research topics of 'Complementary pharmacological and toxicological characterization data on the pharmacological profile of N-(2,6-dichlorophenyl)-2-(4-methyl-1-piperidinyl) acetamide'. Together they form a unique fingerprint.

Cite this